Cohen Klingenstein LLC cut its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 6.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 41,245 shares of the financial services provider's stock after selling 3,000 shares during the period. Cohen Klingenstein LLC's holdings in MetLife were worth $3,377,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in MET. MeadowBrook Investment Advisors LLC grew its position in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after buying an additional 220 shares during the period. Carmichael Hill & Associates Inc. grew its holdings in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC raised its holdings in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock valued at $29,000 after purchasing an additional 277 shares during the period. Peterson Financial Group Inc. bought a new position in shares of MetLife during the 3rd quarter worth about $30,000. Finally, Retirement Wealth Solutions LLC acquired a new stake in shares of MetLife in the 4th quarter valued at about $32,000. Institutional investors own 94.99% of the company's stock.
MetLife Stock Performance
MET traded up $0.94 during midday trading on Friday, reaching $86.83. The company had a trading volume of 5,168,506 shares, compared to its average volume of 2,672,899. MetLife, Inc. has a 12-month low of $64.61 and a 12-month high of $89.05. The business has a 50-day moving average price of $83.41 and a two-hundred day moving average price of $79.47. The stock has a market cap of $60.12 billion, a PE ratio of 17.51, a P/E/G ratio of 0.59 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.51%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio (DPR) is 43.95%.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on MET. StockNews.com lowered MetLife from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. TD Cowen lifted their price target on shares of MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research report on Wednesday, November 27th. Piper Sandler upped their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. Barclays raised their price objective on shares of MetLife from $90.00 to $96.00 and gave the company an "overweight" rating in a research note on Monday, January 6th. Finally, JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a report on Tuesday, January 7th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, MetLife has an average rating of "Moderate Buy" and a consensus price target of $89.92.
Get Our Latest Research Report on MetLife
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.